Total Payments
$972.27
2024 Payments
$319.79
Companies
10
Transactions
34
Medicare Patients
2,467
Medicare Billing
$307,679

Payment Breakdown by Category

Food & Beverage$972.27 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $972.27 34 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $350.01 6 $0 (2023)
ABBVIE INC. $196.88 8 $0 (2024)
PFIZER INC. $195.94 9 $0 (2024)
Novartis Pharmaceuticals Corporation $64.46 3 $0 (2024)
Janssen Pharmaceuticals, Inc $55.85 3 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $29.38 1 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $27.31 1 $0 (2023)
Merck Sharp & Dohme Corporation $22.46 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $16.89 1 $0 (2022)
Lilly USA, LLC $13.09 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $319.79 14 PFIZER INC. ($97.16)
2023 $469.23 14 E.R. Squibb & Sons, L.L.C. ($240.31)
2022 $70.16 4 PFIZER INC. ($34.20)
2021 $22.46 1 Merck Sharp & Dohme Corporation ($22.46)
2020 $90.63 1 E.R. Squibb & Sons, L.L.C. ($90.63)

All Payment Transactions

34 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/12/2024 ABBVIE INC. DALVANCE (Drug), TEFLARO Food and Beverage In-kind items and services $23.05 General
Category: ANTI-INFECTIVE
10/03/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT, ZAVZPRET Food and Beverage In-kind items and services $22.98 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/22/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.43 General
Category: Cardiovascular & Metabolism
08/07/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $23.82 General
Category: ANTI-INFECTIVE
07/11/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $25.43 General
Category: Cardiology/Vascular Diseases
05/30/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $24.07 General
Category: ANTI-INFECTIVE
05/02/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT, ZAVZPRET Food and Beverage In-kind items and services $24.40 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/01/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $22.29 General
Category: Cardiology/Vascular Diseases
04/18/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.70 General
Category: Cardiovascular & Metabolism
04/03/2024 ABBVIE INC. AVYCAZ (Drug), DALVANCE Food and Beverage In-kind items and services $20.72 General
Category: ANTI-INFECTIVE
03/09/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $29.78 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
01/24/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.74 General
Category: Cardiology/Vascular Diseases
01/16/2024 Takeda Pharmaceuticals U.S.A., Inc. NINLARO (Drug) Food and Beverage In-kind items and services $29.38 General
Category: ONCOLOGY
01/11/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT, ZAVZPRET Food and Beverage In-kind items and services $20.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/13/2023 AbbVie Inc. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $25.75 General
Category: ANTI-INFECTIVE
11/29/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $132.19 General
Category: Cardiovascular
11/17/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $20.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/08/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $1.65 General
Category: Cardiovascular
10/26/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $26.47 General
Category: ANTI-INFECTIVE
10/18/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $18.89 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/21/2023 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $26.41 General
Category: ANTI-INFECTIVE
08/25/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID Food and Beverage In-kind items and services $25.69 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/25/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $1.61 General
Category: Cardiovascular
08/22/2023 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $27.31 General
Category: DIABETES
08/01/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $13.09 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 482 749 $182,559 $69,255
2022 10 678 1,242 $261,838 $88,482
2021 7 682 1,209 $245,805 $81,979
2020 8 625 1,096 $205,914 $67,963
Total Patients
2,467
Total Services
4,296
Medicare Billing
$307,679
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 112 262 $53,993 $23,461 43.5%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 140 144 $55,532 $18,191 32.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 104 197 $33,700 $11,667 34.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 101 105 $21,398 $9,213 43.1%
99291 Critical care, first 30-74 minutes Facility 2023 25 41 $17,936 $6,723 37.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 208 590 $118,000 $30,709 26.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 140 144 $46,800 $20,790 44.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 83 209 $47,025 $15,851 33.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 148 155 $27,900 $12,215 43.8%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 15 15 $4,875 $2,048 42.0%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 31 65 $5,200 $1,944 37.4%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 13 13 $3,393 $1,554 45.8%
99283 Emergency department visit for problem of moderate severity Facility 2022 16 27 $3,375 $1,296 38.4%
99284 Emergency department visit for problem of high severity Facility 2022 13 13 $2,795 $1,112 39.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 11 11 $2,475 $963.42 38.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 254 683 $136,600 $36,477 26.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 181 192 $34,560 $15,078 43.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 79 81 $26,325 $12,477 47.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 62 135 $30,375 $10,638 35.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 53 54 $12,150 $5,343 44.0%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 38 49 $3,920 $1,290 32.9%
99217 Hospital observation care on day of discharge Facility 2021 15 15 $1,875 $675.36 36.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 237 624 $124,800 $33,843 27.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 198 209 $37,620 $16,821 44.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 35 62 $13,950 $4,936 35.4%

About Dr. Harnick Dhillon, MD

Dr. Harnick Dhillon, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1114336724.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harnick Dhillon, MD has received a total of $972.27 in payments from pharmaceutical and medical device companies, with $319.79 received in 2024. These payments were reported across 34 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($972.27).

As a Medicare-enrolled provider, Dhillon has provided services to 2,467 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $307,679. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

Products in Payments

  • ELIQUIS (Drug) $412.11
  • CAMZYOS (Drug) $133.84
  • TEFLARO (Drug) $100.23
  • DALVANCE (Drug) $75.93
  • ENTRESTO (Drug) $64.46
  • XARELTO (Drug) $55.85
  • JARDIANCE (Drug) $40.40
  • NINLARO (Drug) $29.38
  • VERQUVO (Drug) $22.46
  • AVYCAZ (Drug) $20.72

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Syracuse